Clinical manifestations of sarin nerve gas exposure.

CHEMICAL WARFARE HAS EXisted for millennia. As far back as 1000 BC, the Chinese used arsenical smoke as a weapon. In the last century, chemical agents have been used in warfare on numerous occasions, from World War I to the Iran-Iraq conflict. The world remains vulnerable to the deliberate use of chemical agents as weapons of mass destruction. Chemical attacks can be delivered with almost any type of conventional ballistic weapon, spray device, or by nontraditional means, such as that used by the Aum Shinrikyo religious cult to launch 2 attacks in public places in Japan by using sarin gas. The first attack occurred in Matsumoto, Japan, in June 1994. The second attack occurred in a Tokyo subway in March 1995. Terrorists involved in this attack carried diluted sarin solution in plastic bags into subway trains and punctured the bags with sharpened umbrella tips. This released diluted sarin vapor into 3 convergent lines of the Tokyo subway system. This attack is the largest disaster caused by nerve gas in peacetime history. These attacks illustrated how an ill-prepared disaster management system can become overwhelmed. Sarin is a highly toxic nerve agent that can be fatal within minutes to hours. It was first synthesized in Germany in 1937 as an insecticide, although its battlefield potential was soon recognized. During World War II, Germany prepared thousands of tons of the potent nerve agents tabun and sarin but refrained from using them. Sarin was first used in wartime during the IranIraq conflict in the 1980s.

[1]  A. Ludolph,et al.  Experimental and clinical neurotoxicology , 1980 .

[2]  J. Parrish,et al.  Vesicants and nerve agents in chemical warfare , 2002, Postgraduate medicine.

[3]  S Kobayashi,et al.  Unexpected nerve gas exposure in the city of Matsumoto: report of rescue activity in the first sarin gas terrorism. , 1997, The American journal of emergency medicine.

[4]  S. Fujishima,et al.  Relationship between pupil size and acetylcholinesterase activity in patients exposed to sarin vapor , 1997, Intensive Care Medicine.

[5]  K. Murata,et al.  A preliminary study on delayed vestibulo-cerebellar effects of Tokyo Subway Sarin Poisoning in relation to gender difference: frequency analysis of postural sway. , 1998, Journal of occupational and environmental medicine.

[6]  M. Maroni,et al.  Organophosphorous compounds. , 1994, Toxicology.

[7]  T Okumura,et al.  The Tokyo subway sarin attack: disaster management, Part 3: National and international responses. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[8]  M. Brown,et al.  Review of health consequences from high‐, intermediate‐ and low‐level exposure to organophosphorus nerve agents , 1998, Journal of applied toxicology : JAT.

[9]  J. Graham,et al.  Cardiomyopathy in Soman and Sarin intoxicated rats. , 1987, Toxicology letters.

[10]  B. Jabbari,et al.  Nerve agents , 1992, Neurology.

[11]  W. Dewey,et al.  Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice. , 1989, Journal of toxicology and environmental health.

[12]  Harold C. Sox,et al.  Gulf War and Health , 2000 .

[13]  E. Albuquerque,et al.  An analysis of low level doses of cholinesterase inhibitors in cultured neurons and hippocampal slices of rats. , 1998, Drug and chemical toxicology.

[14]  A. Gray Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents. , 1984, Drug metabolism reviews.

[15]  T Okumura,et al.  The Tokyo subway sarin attack: disaster management, Part 2: Hospital response. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[16]  J. Woodall Tokyo subway gas attack , 1997, The Lancet.

[17]  J. Borak,et al.  Chemical warfare agents: II. Nerve agents. , 1992, Annals of emergency medicine.

[18]  M. Kirk,et al.  Chemical warfare. Nerve agent poisoning , 1997 .

[19]  E. Albuquerque,et al.  The organophosphate sarin, at low concentrations, inhibits the evoked release of GABA in rat hippocampal slices. , 1999, Neurotoxicology.

[20]  Satu M. Somani,et al.  Chemical warfare agents , 1992 .